Cargando…
Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up
AIMS : Clinical trials have demonstrated the safety and efficacy of the Micra leadless VVI pacemaker; however, longer-term outcomes in a large, real-world population with a contemporaneous comparison to transvenous VVI pacemakers have not been examined. We compared reinterventions, chronic complicat...
Autores principales: | El-Chami, Mikhael F, Bockstedt, Lindsay, Longacre, Colleen, Higuera, Lucas, Stromberg, Kurt, Crossley, George, Kowal, Robert C, Piccini, Jonathan P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934700/ https://www.ncbi.nlm.nih.gov/pubmed/34788416 http://dx.doi.org/10.1093/eurheartj/ehab767 |
Ejemplares similares
-
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker
por: Piccini, Jonathan P., et al.
Publicado: (2021) -
Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups
por: Boveda, Serge, et al.
Publicado: (2023) -
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
por: Knops, Reinoud E, et al.
Publicado: (2022) -
Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
por: Wherry, Kael, et al.
Publicado: (2020) -
Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker
por: El‐Chami, Mikhael F., et al.
Publicado: (2021)